/Alveolus Bio Secures Strategic Investment from Shilpa Medicare to Advance Groundbreaking Pulmonary TherapeuticsUSA - EnglishUSA - EnglishUSA - DeutschUSA - Français
NEWS
Alveolus Bio Secures Strategic Investment from Shilpa Medicare to Advance Groundbreaking Pulmonary TherapeuticsUSA - EnglishUSA - EnglishUSA - DeutschUSA - Français
PRNewswire
2025/08/04Alveolus Bio Secures Strategic Investment from Shilpa Medicare to Advance Groundbreaking Pulmonary TherapeuticsUSA - EnglishUSA - EnglishUSA - DeutschUSA - Français
Shilpa_Logo
Alveolus_Logo
Summary
/PRNewswire/ -- Alveolus Bio, a pioneering respiratory drug development biotech company founded by Dr. Vivek Lal from University of Alabama at Birmingham, AL,...